Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 44Breast Neoplasms 30Lymphoma 29Sarcoma 27Hodgkin Disease 24Triple Negative Breast Neoplasms 20Burkitt Lymphoma 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Neoplasms 15Lymphoma, Follicular 15Ovarian Neoplasms 14Lymphoma, B-Cell 14Lymphoma, Non-Hodgkin 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, T-Cell, Peripheral 9Endometrial Neoplasms 9Neuroblastoma 7Neoplasm Metastasis 7Lymphoma, Mantle-Cell 7Liposarcoma 7Leukemia 7Fallopian Tube Neoplasms 7Recurrence 6Multiple Myeloma 6Leiomyosarcoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Osteosarcoma 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Inflammatory Breast Neoplasms 5

Interventions

Watchful Waiting 1Vincristine 1Topotecan 1Specimen Handling 1Razoxane 1Observation 1Magnetic Resonance Spectroscopy 1Ifosfamide 1High-Energy Shock Waves 1Doxorubicin 1Dexrazoxane 1Dactinomycin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleuropulmonary blastoma × Doxorubicin × 1 year × Clear all
NCT06647953 2026-05-05

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Children's Oncology Group

Phase 3 Recruiting
110 enrolled

Pleuropulmonary blastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡